<html>
<head>PUBMED IDs for CBY1</head>
<body bgcolor='#C5F0F2'><h1>CBY1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16175604/'>Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.</a> September 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19530245/'>WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?</a> October 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19838061/'>Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).</a> February 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25389112/'>DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.</a> March 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25389088/'>SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.</a> January 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26147002/'>14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.</a> April 14  2015<br></body></html>
